Atlas Trials

Lenalidomide and Obinutuzumab for Previously Untreated CLL

Clinical trial NCT02371590 · WITHDRAWN

Trial details

NCT number
NCT02371590
Sponsor
University of California, San Diego
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Lymphocytic Leukemia
Start date
2018-02-01
Primary completion
2019-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.